Medicine and Dentistry
Matrix Metalloproteinase
100%
Metalloprotease Inhibitor
100%
Neoplasm
57%
Biopsy Technique
57%
Reverse Transcription Polymerase Chain Reaction
57%
Gelatinase B
42%
Tissue Inhibitor of Metalloproteinase 1
42%
Gelatinase A
42%
Tissue Inhibitor of Metalloproteinase 2
42%
Lymph Node Metastasis
14%
Preoperative Evaluation
14%
Mucosa
14%
Metastatic Carcinoma
14%
Cancer Staging
14%
Immunohistochemistry
14%
Stomach Adenocarcinoma
14%
Stomach Carcinoma
14%
Tumor Invasion
14%
Proteinase
14%
Monoclonal Antibody
14%
Messenger RNA
14%
Pharmacology, Toxicology and Pharmaceutical Science
Tissue Inhibitor of Metalloproteinase
100%
Matrix Metalloproteinase 14
100%
Matrix Metalloproteinase
100%
RNA Directed DNA Polymerase
57%
Neoplasm
57%
Gelatinase B
42%
Gelatinase A
42%
Tissue Inhibitor of Metalloproteinase 2
42%
Tissue Inhibitor of Metalloproteinase 1
42%
Proteinase
14%
Lymph Node Metastasis
14%
Tumor Invasion
14%
Stomach Carcinoma
14%
Stomach Adenocarcinoma
14%
Monoclonal Antibody
14%
Cancer Staging
14%
Messenger RNA
14%
Biochemistry, Genetics and Molecular Biology
Tissue Level
100%
Matrix Metalloproteinase
100%
Metalloprotease Inhibitor
100%
Membrane-Type Matrix Metalloproteinase-1
70%
Reverse Transcription Polymerase Chain Reaction
40%
Gelatinase B
30%
MMP9
30%
Gelatinase A
30%
MMP2
30%
Mucosa
10%
Negative Staining
10%
Monoclonal Antibody
10%
Cancer Staging
10%
Messenger RNA
10%
Peptidase
10%